Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study.
Taylor PC, Ancuta C, Nagy O, de la Vega MC, Gordeev A, Janková R, Kalyoncu U, Lagunes-Galindo I, Morović-Vergles J, de Souza MPGUES, Rojkovich B, Sidiropoulos P, Kawakami A. Taylor PC, et al. Among authors: kalyoncu u. Patient Prefer Adherence. 2021 Feb 17;15:359-373. doi: 10.2147/PPA.S289692. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33633444 Free PMC article.
Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results.
Armagan B, Sari A, Erden A, Kilic L, Erdat EC, Kilickap S, Kiraz S, Bilgen SA, Karadag O, Akdogan A, Ertenli I, Kalyoncu U. Armagan B, et al. Among authors: kalyoncu u. Medicine (Baltimore). 2018 Mar;97(13):e9930. doi: 10.1097/MD.0000000000009930. Medicine (Baltimore). 2018. PMID: 29595700 Free PMC article.
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.
Sandal Uzun G, Taghiyeva A, Çakır İY, Moral K, Yardımcı GK, Bölek EÇ, Farisoğulları B, Duran E, Ayan G, Özsoy Z, Ekici M, Unaldı E, Germe ŞA, Fırlatan B, Kart-Bayram GS, Bilgin E, Kılıç L, Karadağ Ö, Akdoğan A, Bilgen ŞA, Kiraz S, Ertenli AI, Kalyoncu U. Sandal Uzun G, et al. Among authors: kalyoncu u. Int J Rheum Dis. 2024 Jan;27(1):e14967. doi: 10.1111/1756-185X.14967. Epub 2023 Dec 6. Int J Rheum Dis. 2024. PMID: 38057290
Impact of rheumatoid arthritis in Turkey: a questionnaire study.
Direskeneli H, Akkoç N, Bes C, Cakir N, Cefle A, Cobankara V, Dalkilic E, Dinc A, Ertenli I, Gul A, Hamuryudan V, Inanc M, Kalyoncu U, Karaaslan Y, Kasifoglu T, Keser G, Keskin G, Kisacik B, Kiraz S, Masatlioglu S, Onat AM, Ozbek S, Ozturk MA, Pamuk ON, Pay S, Pirildar T, Sayarlioglu M, Senel S, Senturk T, Tasan D, Terzioglu E, Yazici A, Yucel E. Direskeneli H, et al. Among authors: kalyoncu u. Clin Exp Rheumatol. 2014 Jul-Aug;32(4):477-83. Epub 2014 Jun 6. Clin Exp Rheumatol. 2014. PMID: 24960289
Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results.
Ayan G, Farisogulları B, Bilgin E, Bolek EC, KübraYardımcı G, Duran E, Ozsoy Z, Uzun GS, Kilic L, Akdoğan A, Karadag O, Bilgen ŞA, Kiraz S, Ertenli Aİ, Kalyoncu U. Ayan G, et al. Among authors: kalyoncu u. Clin Rheumatol. 2022 May;41(5):1439-1446. doi: 10.1007/s10067-021-06012-y. Epub 2022 Jan 27. Clin Rheumatol. 2022. PMID: 35088209
Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study.
Direskeneli H, Karadag O, Ates A, Tufan A, Inanc N, Koca SS, Cetin GY, Akar S, Cinar M, Yilmaz S, Yilmaz N, Dalkilic E, Bes C, Yilmazer B, Sahin A, Ersözlü D, Tezcan ME, Sen N, Keser G, Kalyoncu U, Armagan B, Hacibedel B, Helvacioglu K, Cesur TY, Basibuyuk CS, Alkan S, Gunay LM. Direskeneli H, et al. Among authors: kalyoncu u. Rheumatol Adv Pract. 2022 Sep 2;6(3):rkac071. doi: 10.1093/rap/rkac071. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 36133962 Free PMC article.
201 results